Clinical Trials Directory

Trials / Completed

CompletedNCT02472951

Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Bispebjerg Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Scientific evidence for the dietary treatment of type 2 diabetes is insufficient. The investigators hypothesize that a lower carbohydrate content in the diabetic diet than the recommended 55 E% will decrease the postprandial glucose excursion, decrease insulinotropic factors like incretin hormones and decrease their insulinotropic effects due to their glucose dependency. This will reduce postprandial insulin concentration, resulting in an improved insulin sensitivity and glucose metabolism. This clinical study will examine in diabetic, prediabetic and healthy subjects the acute effects of short term highly controlled dietary low carbohydrate intervention on metabolic pathways with respect to insulin action, pancreatic islet function, lipid metabolism, incretin hormones, low grade inflammation in plasma and novel measures of fatty acid metabolism.

Conditions

Interventions

TypeNameDescription
OTHERLow carbohydrate mealsMeal macronutritional energy composition: Carbohydrate 30% Protein 30% Fat 40%
OTHERStandard carbohydrate mealsMeal macronutritional energy composition: Carbohydrate 55% Protein 15% Fat 30%

Timeline

Start date
2015-08-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2015-06-16
Last updated
2018-03-02

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02472951. Inclusion in this directory is not an endorsement.